Pentadecapeptide (BPC Analog)
Nature's tissue-healing peptide from gastric juice—a 15-amino acid powerhouse for recovery
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
200 – 500 mcg
Compound profile
Pentadecapeptide (BPC Analog) scientific & efficacy data
Healing & Recovery
Peptide profile
Moderate human trials
Pentadecapeptide (BPC Analog)
250 mcg · Once daily
Molecular formula
C62H98N16O22
- Mol. weight
- 1419.5 g/mol
- CAS number
- Not assigned (research compound)
- PubChem
- 9941957
- Developed · 1990
- Vladimir Khavinson Research Team
Russian Academy of Sciences
Amino acid sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-ValTissue Repair & Recovery
Multiple studies show BPC-157 significantly accelerates healing of tendons, ligaments, and muscles by promoting cell growth and migration
Angiogenesis (Blood Vessel Formation)
The peptide stimulates new blood vessel formation, increasing oxygen and nutrient delivery to injured tissues
Anti-Inflammatory Effects
Reduces inflammatory markers in damaged tissue, creating an optimal environment for healing
Dosing
How much Pentadecapeptide (BPC Analog) do I take?
200 – 500 mcg
200 – 500 mcg
| Phase | Dose | Frequency |
|---|---|---|
| Weeks 1-2 | 250 mcg | Once daily |
| Weeks 4-6 | 200-500 mcg | Once or twice daily |
| Weeks 6-8 | 500 mcg | Twice daily |
Covers all 3 documented dose levels · timing · dose-adjustment guidance.
Suitability
Is Pentadecapeptide (BPC Analog) right for me?
Best for recovering from sports injuries or muscle strains & supporting post-surgery tissue repair
Best for
Recovering from sports injuries or muscle strains
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on recovering from sports injuries or muscle strains. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Supporting post-surgery tissue repair
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on supporting post-surgery tissue repair. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Accelerating tendon and ligament healing
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on accelerating tendon and ligament healing. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Improving overall recovery speed
Pentadecapeptide (BPC Analog) is particularly well-suited for individuals focused on improving overall recovery speed. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Pentadecapeptide (BPC Analog) with similar peptides to find the best fit for your goals.
Administration
How do I use Pentadecapeptide (BPC Analog)?
Intramuscular injection · Subcutaneous injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is Pentadecapeptide (BPC Analog) safe?
3 common side effects · 1 serious
BPC-157 analogs show favorable safety in animal toxicity studies with LD50 >1000 mg/kg (oral, rats).
No serious adverse events in limited clinical case reports; mild local injection site effects observed. Gastroprotective mechanism suggests low systemic toxicity; rapid hepatic metabolism limits systemic exposure.
Preclinical studies show no mutagenicity, carcinogenicity, or teratogenicity; reproductive safety appears favorable.
Mechanistic studies using histopathology and immunohistochemistry demonstrate protective effects against gastric ulcers (Shay ulcer model); vascular healing enhancement shown through angiogenesis markers (VEGF, HIF-1α expression via qRT-PCR).
Bone healing studies using mechanical testing show 30-50% increased fracture strength. Neurotrophic effects documented through GDNF and BDNF expression increases in central/peripheral nervous tissue.
Common side effects · experienced by some users
Injection site irritation
Redness, slight swelling, or discomfort at injection site. Typically resolves within a few hours.
Management: Rotate injection sites, use ice if needed, ensure sterile technique
Headache
Occasional headache reported, especially in early use. Usually mild and temporary.
Management: Ensure adequate hydration, take over-the-counter pain relief if needed
Nausea
More common with oral administration. Can usually be minimized with proper dosing timing.
Management: Take with food, use parenteral (injection) routes instead if oral causes issues
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Pentadecapeptide (BPC Analog)
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Pentadecapeptide (BPC Analog) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
With medications
- Caution:Immunosuppressants — May interfere with peptide's immune-modulating effects
With supplements
- Safe:Multivitamins — Generally safe to take alongside Pentadecapeptide (BPC Analog). Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know Pentadecapeptide (BPC Analog) is working?
Moderate human trials · first signs immediate (0-24 hours) (first day)
Evidence level
Moderate human trials
(Phase 1-2)
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
BPC-157 is a protective peptide found in stomach acid that promotes healing and reduces inflammation.
It's being studied for gut injuries, muscle injuries, and neurological conditions where tissue repair and neuroprotection are needed.
The deeper mechanism
BPC-157 is a 15-amino acid peptide that activates multiple growth factor pathways including VEGF and bFGF signaling, promoting angiogenesis, fibroblast proliferation, and tissue healing.
What to expect
Immediate (0-24 hours) (First day)
What you might notice
- Initial injection site sensation
- Body recognizes peptide signal
- No major systemic effects yet
What's normal
- Initial response to Pentadecapeptide (BPC Analog) is beginning at the cellular level
- Different individuals experience Pentadecapeptide (BPC Analog)'s onset at different rates
- Transient systemic effects from initial Pentadecapeptide (BPC Analog) exposure are common
What's next
- Maintain consistent Pentadecapeptide (BPC Analog) administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Early Response (1-2 weeks) (Days 1-14)
What you might notice
- Cells at injury sites start receiving growth and migration signals
- Users may notice improved pain or movement
What's normal
- Pentadecapeptide (BPC Analog) is achieving sufficient receptor engagement
- Initial mechanism of Pentadecapeptide (BPC Analog) is taking effect
- Early transient effects from Pentadecapeptide (BPC Analog) administration are resolving
What's next
- Maintain consistent Pentadecapeptide (BPC Analog) administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
Active Repair (2-4 weeks) (Weeks 2-4)
What you might notice
- New blood vessels forming at injury site
- Cell proliferation and tissue remodeling accelerates
- Significant functional improvement often visible
What's normal
- Pentadecapeptide (BPC Analog) is now achieving steady-state pharmacokinetics
- Measurable changes aligned with Pentadecapeptide (BPC Analog)'s mechanism may appear
- Initial adjustment effects typically resolve by this point
What's next
- Maintain Pentadecapeptide (BPC Analog) dosing exactly as established
- Track progress toward intended outcomes in detail
- Review lab work or biomarker changes with your healthcare team
Continued Healing (4-8 weeks) (Weeks 4-8)
What you might notice
- Tissue gains strength as collagen reorganizes
- Full functional restoration becomes apparent
- Most users report significant recovery by this point
What's normal
- Pentadecapeptide (BPC Analog) is now achieving steady-state pharmacokinetics
- Measurable changes aligned with Pentadecapeptide (BPC Analog)'s mechanism may appear
- Initial adjustment effects typically resolve by this point
What's next
- Maintain Pentadecapeptide (BPC Analog) dosing exactly as established
- Track progress toward intended outcomes in detail
- Review lab work or biomarker changes with your healthcare team
Maturation (8-12 weeks) (Weeks 8-12)
What you might notice
- Tissue remodeling completes
- Healing plateaus
- Consider discontinuing or switching to lower maintenance dose
What's normal
- Full therapeutic effects of Pentadecapeptide (BPC Analog) are well-characterized at this point
- Maintenance of Pentadecapeptide (BPC Analog)'s therapeutic effects is typical
- Tolerance patterns with Pentadecapeptide (BPC Analog) are generally stable over months
What's next
- Comprehensive assessment of Pentadecapeptide (BPC Analog) efficacy should be conducted
- Discuss long-term continuation, cycling, or protocol modifications
- Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Pentadecapeptide (BPC Analog) over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked about Pentadecapeptide (BPC Analog)
Is BPC-157 the same as BPC (Body Protection Compound)?
BPC-157 is specifically the 15-amino acid fragment of the larger Body Protection Compound found in gastric juice. When people say 'BPC-157,' they're usually referring to this pentadecapeptide version, which is the most studied and used form.
How is BPC-157 discovered naturally in the body?
BPC-157 was isolated from human gastric juice during research into stomach health and protection. Your body naturally produces this peptide as part of protective mechanisms in the digestive system, which is why it's sometimes called 'gastric pentadecapeptide.'
Can I take BPC-157 orally?
Technically yes, but it's not ideal. Peptides are proteins and get broken down by stomach acid and digestive enzymes. Injection (intramuscular or subcutaneous) is much more effective because it bypasses these obstacles and gets the full dose into circulation.
How long does a cycle typically last?
Most research protocols use 6-8 week cycles for acute injuries, then reassess. Some people do longer maintenance at lower doses. Listen to your body and your healthcare provider—recovery timelines vary based on injury severity.
Will BPC-157 help my old injury?
BPC-157 shows promise for chronic injuries, but it works best on fresh injuries. That said, tissue remodeling can happen at any stage, so it may still help, just potentially slower. Research is ongoing for chronic conditions.
Is it safe for athletes?
BPC-157 is not a banned substance in most sports organizations since it's not performance-enhancing. However, it's a research compound without full clinical approval. Athletes should verify their sport's specific rules and consult healthcare providers.
What's the difference between BPC-157 analogs?
Analogs are slight chemical variations of the original peptide, designed to improve stability, absorption, or reduce side effects. Different analogs may have tweaked amino acid sequences but serve similar healing functions. Quality and purity vary by manufacturer.
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Pentadecapeptide (BPC Analog), on one page.